Future in-depth characterization of both the cytosolic and organellar impacts of ATP13A4’s transport function will be instrumental in further understanding its role in (breast) cancer and may validate ATP13A4 as a candidate therapeutic target for anticancer drugs that block the PTS. This evidence concerns the gene ATP13A4 and breast carcinoma.